Published guidance, NICE advice and quality standards | Guidance

Showing 861 to 870 of 2500

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Secondary bacterial infection of eczema and other common skin conditions: antimicrobial prescribing	NG190	2 March 2021	2 March 2021
Safeguarding adults in care homes	NG189	26 February 2021	26 February 2021
Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitis	ES35	24 February 2021	24 February 2021
Metreleptin for treating lipodystrophy	HST14	24 February 2021	24 February 2021
Filgotinib for treating moderate to severe rheumatoid arthritis	TA676	24 February 2021	24 February 2021
Brexucabtagene autoleucel for treating relapsed or refractory mantle cell lymphoma	TA677	24 February 2021	24 February 2021
Omalizumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal)	TA678	24 February 2021	24 February 2021
Dapagliflozin for treating chronic heart failure with reduced ejection fraction	TA679	24 February 2021	24 February 2021
Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy	TA673	17 February 2021	17 February 2021
Pembrolizumab for untreated PD-L1-positive, locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (terminated appraisal)	TA674	17 February 2021	17 February 2021